163 related articles for article (PubMed ID: 10492375)
1. A new rectal model for dosimetry applications.
Mardirossian G; Tagesson M; Blanco P; Bouchet LG; Stabin M; Yoriyaz H; Baza S; Ljungberg M; Strand SE; Brill AB
J Nucl Med; 1999 Sep; 40(9):1524-31. PubMed ID: 10492375
[TBL] [Abstract][Full Text] [Related]
2. DOSE3D: EGS4 Monte Carlo code-based software for internal radionuclide dosimetry.
Clairand I; Ricard M; Gouriou J; Di Paola M; Aubert B
J Nucl Med; 1999 Sep; 40(9):1517-23. PubMed ID: 10492374
[TBL] [Abstract][Full Text] [Related]
3. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine.
Thomas SR; Stabin MG; Chen CT; Samaratunga RC
J Nucl Med; 1999 Apr; 40(4):102S-123S. PubMed ID: 10210232
[TBL] [Abstract][Full Text] [Related]
4. On the need to revise the arm structure in stylized anthropomorphic phantoms in lateral photon irradiation geometry.
Lee C; Lee C; Lee JK
Phys Med Biol; 2006 Nov; 51(21):N393-402. PubMed ID: 17047258
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
[TBL] [Abstract][Full Text] [Related]
6. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
7. Estimated radiation dose to the newborn in FDG-PET studies.
Ruotsalainen U; Suhonen-Polvi H; Eronen E; Kinnala A; Bergman J; Haaparanta M; Teräs M; Solin O; Wegelius U
J Nucl Med; 1996 Feb; 37(2):387-93. PubMed ID: 8667081
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of parameters influencing S values in mouse dosimetry.
Hindorf C; Ljungberg M; Strand SE
J Nucl Med; 2004 Nov; 45(11):1960-5. PubMed ID: 15534069
[TBL] [Abstract][Full Text] [Related]
10. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Brown WD; Oakes TR; DeJesus OT; Taylor MD; Roberts AD; Nickles RJ; Holden JE
J Nucl Med; 1998 Nov; 39(11):1884-91. PubMed ID: 9829576
[TBL] [Abstract][Full Text] [Related]
12. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
14. Consideration of the ICRP 2006 revised tissue weighting factors on age-dependent values of the effective dose for external photons.
Lee C; Lee C; Han EY; Bolch WE
Phys Med Biol; 2007 Jan; 52(1):41-58. PubMed ID: 17183127
[TBL] [Abstract][Full Text] [Related]
15. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Konijnenberg MW; Bijster M; Krenning EP; De Jong M
J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
[TBL] [Abstract][Full Text] [Related]
16. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
17. Revisions to the ORNL series of adult and pediatric computational phantoms for use with the MIRD schema.
Han EY; Bolch WE; Eckerman KF
Health Phys; 2006 Apr; 90(4):337-56. PubMed ID: 16538139
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
[TBL] [Abstract][Full Text] [Related]
19. A model of the prostate gland for use in internal dosimetry.
Stabin MG
J Nucl Med; 1994 Mar; 35(3):516-20. PubMed ID: 8113907
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
